×

3D Printing Index (KDDDP)

Symbol
Name
Price
 
Change
%Change
DDD
---
SHLM
---
ANSS
---
ADSK
---
CFMS
---
CYBE
---
KODK
---
FARO
---
LITE
---
MRVL
---
ONVO
---
PROTO LABS
---
PTC
---
SSYS
---
XONE
---

About Kensho 3D Printing Index

  • 3-D printing technology has developed into an important and versatile tool for a wide variety of industries. Industries use 3-D printers for rapid prototyping, generation-of-scale models and cost-effective, large-scale production of commoditized objects. Companies in the 3-D printing index make 3-D printers and/or specialized components, including modeling software.

Latest Special Reports

  • Top States 2016

    CNBC's annual study measures all 50 states on more than 60 different metrics.

  • CNBC tackles the business of travel in this new special report covering the leisure and hospitality sector.

    From the most innovative hotels to the best ways to be a road warrior, CNBC tackles the business of travel in this new special report covering the leisure and hospitality sector.

  • International business and political leaders gather in Dalian, China for the 2017 instalment of the World Economic Forum’s Annual Meeting of the New Champions.

Kensho Stats

  • What happens after a Russell re-balancing

    Before the break our data partners at Kensho on what happens after a Russell re-balancing. We've seen 17 of them since the year 2000. A month later the S&P us up more than once percent while the Russel falls point fifty seven percent. For more Kensho go to CNBC.com/pro. The Halftime Report with Scott Wapner and the traders is back in two minutes.

  • After health care gains eight percent in one quarter

    According to Kensho, health care gains 8% in one quarter with Merck, Bristol-Myers and Pfizer as some of its outperformers.

  • FMHR Three winners after health care jump 170623 EC

    Before the break, health care big cap winners after the sectors jumps eight percent in a quarter our data partners at Kensho show that its happened three times in twelve years. When sold a month after the big jump Merck picks one point seventy-nine percent, Bristol Myers one point seventy-four percent, Pfizer one point forty-eight percent. For more Kensho go to CNBC.com/pro. The Halftime Report with Scott Wapner and the traders are back in two minutes.